GSK Plans International Expansion Of Stiefel's Dermatology Business
This article was originally published in The Rose Sheet
Executive Summary
As part of a "multi-pronged" strategy for leveraging its acquisition of Stiefel Laboratories, GlaxoSmithKline plans to introduce the Coral Gables, Fla. firm's Rx and nonprescription dermatology brands to a global audience
You may also be interested in...
MaxClarity Delivers Anti-Acne Actives Via Penetration-Enhancing Foam
Stiefel Laboratories differentiates its MaxClarity Acne Management System with VersaFoam technology to deliver active ingredients in foam
MaxClarity Delivers Anti-Acne Actives Via Penetration-Enhancing Foam
Stiefel Laboratories differentiates its MaxClarity Acne Management System with VersaFoam technology to deliver active ingredients in foam
GSK Iso-Active Toothpastes Employ Double Foam, Claim Triple Efficacy
GlaxoSmithKline is replacing the conventional toothpaste tube with a canister like those used for shaving products to deliver its new Aquafresh and Sensodyne products with "twice the foam volume as ordinary toothpaste.